EIGR - Eiger BioPharmaceuticals Inc
Close
1.725
-0.175 -10.145%
Share volume: 137,824
Last Updated: Wed 10 Apr 2024 10:00:00 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$1.90
-0.18
-9.21%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | |
| Report Date | 2022-05-05 | 2022-08-04 | 2022-11-03 | 2023-03-17 | 2023-05-11 | 2023-08-14 | 2023-11-09 | |
| Cash flow financing | 45.802 M | 31.301 M | -88.000 K | -60.000 K | 41.000 K | -22.000 K | 15.000 K | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | -18.459 M | -21.744 M | -20.560 M | -22.247 M | -24.005 M | -22.035 M | -14.554 M | |
| Net income | -22.643 M | -21.884 M | -27.111 M | -25.138 M | -22.784 M | -20.695 M | -18.030 M | |
| Depreciation | 205.000 K | 209.000 K | 212.000 K | -334.000 K | 74.000 K | 66.000 K | 78.000 K | |
| Changes in inventories | 1.910 M | 2.876 M | 2.817 M | 2.853 M | 5.338 M | 1.098 M | 1.105 M | |
| Changes in receivables | 2.287 M | 1.038 M | 2.458 M | 1.749 M | 3.891 M | 3.715 M | 1.321 M | |
| Investing Cashflow | -3.002 M | -19.547 M | 10.384 M | 21.797 M | 13.383 M | 29.846 M | 19.000 M | |
| Net Borrowings | -110.570 M | -114.434 M | -97.420 M | -72.734 M | -47.257 M | -25.000 M | -11.259 M | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | -9.000 K | -107.000 K | -224.000 K | -216.000 K | -17.000 K | 0.000 | |
| Cash Change | 132.717 M | 141.792 M | 121.044 M | 98.948 M | 75.272 M | 53.609 M | 39.421 M |